Diagnio

Curated by Signal

At-home hormonal and fertility diagnostics device

Overview

At-home hormonal and fertility diagnostics device. The company offers a Diagnio device that uses a sample of female saliva to measure estrogen levels and determine the cycle phase and ovulation via mobile application.

Key facts

Founded: 2022
Headquarters: Wilmington, United States
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view
Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Company 4 Fit
Provider of a digital platform for physical activity or exercise for employees
Health TechnologyUnited States
Pharmacy Systems
Provider of 340B compliance management software for pharmacists
Health TechnologyFlint, United States
Heads Up Checkup
Online symptom checking platform for behavioural health
Health TechnologyAnaheim, United States

About Diagnio

What does Diagnio do?

At-home hormonal and fertility diagnostics device.

Where is Diagnio headquartered?

Diagnio is headquartered in Wilmington, United States.

When was Diagnio founded?

Diagnio was founded in 2022.

Which sector is Diagnio in?

Diagnio operates in Health Technology.

Who are Diagnio's competitors?

Companies similar to Diagnio include Company 4 Fit, Pharmacy Systems, and Heads Up Checkup.